Cargando…
The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
BACKGROUND: JAK inhibitors treat various autoimmune diseases, but an updated systematic review in treating alopecia areata is currently lacking. OBJECTIVE: Evaluate the specific efficacy and safety of JAK inhibitors in alopecia areata by systematic review and meta-analysis. METHODS: Eligible studies...
Autores principales: | Mao, Mei-qi, Ding, Yu-xin, Jing, Jing, Tang, Zhen-wei, Miao, Yu-jie, Yang, Xiao-shuang, Chen, Yu-hong, Chen, Sheng-zhao, Wu, Xian-jie, Lu, Zhong-fa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272608/ https://www.ncbi.nlm.nih.gov/pubmed/37334349 http://dx.doi.org/10.3389/fimmu.2023.1195858 |
Ejemplares similares
-
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022) -
Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
por: Wei, Dongfan, et al.
Publicado: (2023) -
Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2022) -
Novel potential therapeutic targets of alopecia areata
por: Xu, Wen, et al.
Publicado: (2023) -
The potential of regulatory T cell-based therapies for alopecia areata
por: Wan, Sheng, et al.
Publicado: (2023)